Park, Youn Young
Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma. [electronic resource]
- Medicine Aug 2019
- e16709 p. digital
Publication Type: Journal Article; Observational Study
1536-5964
10.1097/MD.0000000000016709 doi
AC133 Antigen--metabolism
Aged
Biomarkers, Tumor--genetics
Colorectal Neoplasms--genetics
Disease-Free Survival
Female
Humans
Male
Middle Aged
Neoplasm Staging
Neoplastic Stem Cells--metabolism
Retrospective Studies